04 Apr 2026

CRC Research Update — April 04, 2026

Creator: The CRC Digest
Published: 2026-04-04T11:40:32Z

Today's colorectal cancer research highlights

Was this forwarded to you? Read on the web or subscribe free

IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.

Signal Key

TRIAL DATA clinical trial results, efficacy data, survival endpoints TREATMENT new treatment options, regimen changes, combination therapies REGULATORY FDA/EMA approvals, guideline updates, NCCN/ESMO changes RESEARCH cancer biology, biomarker discoveries, resistance pathways SCREENING screening, colonoscopy guidelines, liquid biopsy, molecular profiling LIVING WITH CRC survivorship, quality of life, side effects, patient decision-making, caregiver support

CRC Research Update

Low Expression of DNA Repair Genes Predicts Oxaliplatin Benefit in Metastatic CRC
Analysis of 22,957 metastatic CRC samples found that patients with low RNA expression of homologous recombination genes showed improved survival with oxaliplatin-based therapy, suggesting a new way to identify who benefits most from platinum chemotherapy. (JCO Precision Oncology)
Fecal Hemoglobin Levels Guide Personalized Colonoscopy Surveillance After Polyp Removal
A study of 4 million participants in Taiwan's FIT screening program developed fecal hemoglobin-guided surveillance intervals that balance colonoscopy resource use with cancer prevention after polyp removal. (Gastroenterology)
Patient Navigation and Mailed FIT Kits Most Effective for Boosting Screening Rates
Network analysis of 76 randomized trials identified patient navigation and mailed fecal testing as the most effective strategies to increase colorectal cancer screening uptake among underscreened populations. (Gastroenterology)
Causes of Death Shifting in Colon and Rectal Cancer Patients Over Two Decades
SEER database analysis reveals temporal trends in what causes death among colorectal cancer patients, reflecting changes in treatment approaches, screening age guidelines, and new health threats like COVID-19 over the past 20 years. (Cancer Causes & Control)

🔬 Under 50 Spotlight

Research relevant to early-onset and younger CRC patients

Prognostic Factors Identified for Young Adults with Liver Metastases
Analysis of 3,188 young adults aged 18-45 with stage IV colorectal cancer and liver metastases identified key prognostic factors affecting overall survival. (Discovery Oncology)
Cancer Mortality Projections Through 2026 for Young Adults Across 15 Countries
Study projects early-onset cancer mortality trends through 2026 for ages 25-49 across 15 high-income countries, with special focus on colorectal cancer patterns. (Cancer Causes & Control)

Today's research highlights progress in personalizing treatment and screening strategies — steps toward care that fits each patient's unique cancer profile.

CRC Research Update

Subscribe to The CRC Digest